These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 33138172)
1. A Versatile Macromer-Based Glycosaminoglycan (sHA3) Decorated Biomaterial for Pro-Osteogenic Scavenging of Wnt Antagonists. Gronbach M; Mitrach F; Möller S; Rother S; Friebe S; Mayr SG; Schnabelrauch M; Hintze V; Hacker MC; Schulz-Siegmund M Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33138172 [TBL] [Abstract][Full Text] [Related]
2. Scavenging of Dickkopf-1 by macromer-based biomaterials covalently decorated with sulfated hyaluronan displays pro-osteogenic effects. Gronbach M; Mitrach F; Lidzba V; Müller B; Möller S; Rother S; Salbach-Hirsch J; Hofbauer LC; Schnabelrauch M; Hintze V; Hacker MC; Schulz-Siegmund M Acta Biomater; 2020 Sep; 114():76-89. PubMed ID: 32673749 [TBL] [Abstract][Full Text] [Related]
3. Sulfated hyaluronan improves bone regeneration of diabetic rats by binding sclerostin and enhancing osteoblast function. Picke AK; Salbach-Hirsch J; Hintze V; Rother S; Rauner M; Kascholke C; Möller S; Bernhardt R; Rammelt S; Pisabarro MT; Ruiz-Gómez G; Schnabelrauch M; Schulz-Siegmund M; Hacker MC; Scharnweber D; Hofbauer C; Hofbauer LC Biomaterials; 2016 Jul; 96():11-23. PubMed ID: 27131598 [TBL] [Abstract][Full Text] [Related]
4. Surface modification of copolymerized films from three-armed biodegradable macromers - An analytical platform for modified tissue engineering scaffolds. Müller BM; Loth R; Hoffmeister PG; Zühl F; Kalbitzer L; Hacker MC; Schulz-Siegmund M Acta Biomater; 2017 Mar; 51():148-160. PubMed ID: 28069495 [TBL] [Abstract][Full Text] [Related]
5. Increased pore size of scaffolds improves coating efficiency with sulfated hyaluronan and mineralization capacity of osteoblasts. Krieghoff J; Picke AK; Salbach-Hirsch J; Rother S; Heinemann C; Bernhardt R; Kascholke C; Möller S; Rauner M; Schnabelrauch M; Hintze V; Scharnweber D; Schulz-Siegmund M; Hacker MC; Hofbauer LC; Hofbauer C Biomater Res; 2019; 23():26. PubMed ID: 31890268 [TBL] [Abstract][Full Text] [Related]
6. Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone. Salbach-Hirsch J; Samsonov SA; Hintze V; Hofbauer C; Picke AK; Rauner M; Gehrcke JP; Moeller S; Schnabelrauch M; Scharnweber D; Pisabarro MT; Hofbauer LC Biomaterials; 2015 Oct; 67():335-45. PubMed ID: 26232882 [TBL] [Abstract][Full Text] [Related]
7. Covalent linkage of sulfated hyaluronan to the collagen scaffold Mucograft® enhances scaffold stability and reduces proinflammatory macrophage activation Al-Maawi S; Rother S; Halfter N; Fiebig KM; Moritz J; Moeller S; Schnabelrauch M; Kirkpatrick CJ; Sader R; Wiesmann HP; Scharnweber D; Hintze V; Ghanaati S Bioact Mater; 2022 Feb; 8():420-434. PubMed ID: 34541411 [TBL] [Abstract][Full Text] [Related]
8. Collagen/glycosaminoglycan coatings enhance new bone formation in a critical size bone defect - A pilot study in rats. Förster Y; Bernhardt R; Hintze V; Möller S; Schnabelrauch M; Scharnweber D; Rammelt S Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():84-92. PubMed ID: 27987780 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronan/collagen hydrogel matrices containing high-sulfated hyaluronan microgels for regulating transforming growth factor-β1. Rother S; Krönert V; Hauck N; Berg A; Moeller S; Schnabelrauch M; Thiele J; Scharnweber D; Hintze V J Mater Sci Mater Med; 2019 May; 30(6):65. PubMed ID: 31127393 [TBL] [Abstract][Full Text] [Related]
11. Fabrication of amorphous strontium polyphosphate microparticles that induce mineralization of bone cells in vitro and in vivo. Müller WEG; Tolba E; Ackermann M; Neufurth M; Wang S; Feng Q; Schröder HC; Wang X Acta Biomater; 2017 Mar; 50():89-101. PubMed ID: 28017868 [TBL] [Abstract][Full Text] [Related]
12. Artificial matrices with high-sulfated glycosaminoglycans and collagen are anti-inflammatory and pro-osteogenic for human mesenchymal stromal cells. Hempel U; Matthäus C; Preissler C; Möller S; Hintze V; Dieter P J Cell Biochem; 2014 Sep; 115(9):1561-71. PubMed ID: 24706396 [TBL] [Abstract][Full Text] [Related]
13. Ophiopogonin D improves osteointegration of titanium alloy implants under diabetic conditions by inhibition of ROS overproduction via Wnt/β-catenin signaling pathway. Ma XY; Wen XX; Yang XJ; Zhou DP; Wu Q; Feng YF; Ding HJ; Lei W; Yu HL; Liu B; Xiang LB; Wang TS Biochimie; 2018 Sep; 152():31-42. PubMed ID: 29705132 [TBL] [Abstract][Full Text] [Related]
14. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women. Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386 [TBL] [Abstract][Full Text] [Related]
15. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition. Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318 [TBL] [Abstract][Full Text] [Related]
16. The promotion of osteointegration under diabetic conditions using chitosan/hydroxyapatite composite coating on porous titanium surfaces. Ma XY; Feng YF; Ma ZS; Li X; Wang J; Wang L; Lei W Biomaterials; 2014 Aug; 35(26):7259-70. PubMed ID: 24912815 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation. Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393 [TBL] [Abstract][Full Text] [Related]
18. Biodegradable and adjustable sol-gel glass based hybrid scaffolds from multi-armed oligomeric building blocks. Kascholke C; Hendrikx S; Flath T; Kuzmenka D; Dörfler HM; Schumann D; Gressenbuch M; Schulze FP; Schulz-Siegmund M; Hacker MC Acta Biomater; 2017 Nov; 63():336-349. PubMed ID: 28927930 [TBL] [Abstract][Full Text] [Related]
19. Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume. Morse A; Cheng TL; Schindeler A; McDonald MM; Mohanty ST; Kneissel M; Kramer I; Little DG Calcif Tissue Int; 2018 Sep; 103(3):298-310. PubMed ID: 29845410 [TBL] [Abstract][Full Text] [Related]
20. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]